Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 7, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 7, Status: Authorised
AAdmin
٢٨ يوليو ٢٠٢٦
1 دقيقة قراءة
